Home › Encyclopedia › Ecnoglutide: Investigational Peptide Overview
Research / Unapproved

Ecnoglutide: Investigational Peptide Overview

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC194H304N48O61
Molecular weight4285 g/mol
Registered trials14
PubChem CID162625103

Regulatory status

Ecnoglutide is an investigational compound. It does not carry an FDA-approved label, and no approved brand names or indications exist for it.

What ecnoglutide is

Ecnoglutide is a large synthetic peptide, with a molecular formula of C194H304N48O61 and a molecular weight of approximately 4,285 (PubChem CID 162625103). Because no approved label exists, mechanism of action and approved use cannot be described from labeling data.

Clinical trial activity

Ecnoglutide has been registered in 14 clinical trials to date. One completed study examined drug-drug interactions between ecnoglutide and metformin, warfarin, rosuvastatin, and digoxin. A separate completed trial evaluated ecnoglutide in adults with overweight or obesity, and a currently recruiting trial is studying its use in obese participants with obstructive sleep apnea who are receiving positive airway pressure therapy.

FAQ

What is ecnoglutide?
Ecnoglutide is a large synthetic peptide compound identified by PubChem CID 162625103, with a molecular formula of C194H304N48O61. It is currently classified as an investigational compound rather than an approved medication.
Is ecnoglutide FDA-approved?
No. Ecnoglutide does not have an FDA-approved label, approved brand name, or approved indication. It remains in the research and clinical trial stage.
What clinical trials have studied ecnoglutide?
Ecnoglutide has been registered in 14 clinical trials. Examples include a completed drug interaction study with metformin, warfarin, rosuvastatin, and digoxin, a completed trial in adults with overweight or obesity, and a recruiting trial in obese participants with obstructive sleep apnea.
Does ecnoglutide have any approved uses?
Ecnoglutide has no approved uses at this time. Available information is limited to its chemical identity and its presence in registered clinical trials.
What is the chemical structure of ecnoglutide?
Ecnoglutide has the molecular formula C194H304N48O61 and a molecular weight of approximately 4,285. It is catalogued in PubChem under CID 162625103.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: ClinicalTrials.gov trials registry PubChem compound database

Updated 2026-08-04